Corteva

Corteva makes crop protection products: herbicides, insecticides, fungicides, biologicals and seed-applied treatments that farmers use against weeds, insects and diseases. On October 1, 2026, it spun off its seed business as Vylor Inc., and each Corteva shareholder got one Vylor share for each Corteva share. Corteva kept the crop protection business, the Corteva name and the CTVA ticker. Before the spin-off, Crop Protection had net sales of $3.73 billion and segment operating EBITDA of $776 million in the first half of 2026.

Corteva sells in about 110 countries through distributors and retailers, and new, patented products are about 65% of its sales. It also owns EIDP, the former E. I. du Pont de Nemours and Company, which carries legacy environmental and PFAS liabilities that Corteva shares with DuPont and Chemours under a 2021 agreement.

The market prices Corteva at a discount because the company that remained after the spin-off holds the legacy PFAS liabilities of the old DuPont, and these liabilities have no clear limit. Fifteen US states and one sovereign sued on October 1, 2026 to challenge the spin-off. On October 9, a federal court in Indiana issued a temporary order that stopped dividends, buybacks and asset sales outside normal business, but the court stayed the order on October 10 while Corteva appeals to the Seventh Circuit. Crop chemicals also face price pressure from cheap generic products: Crop Protection prices fell 4% in Q2 2026, mainly in Latin America, and rival FMC cut its Q3 outlook sharply on October 15, 2026.

For the gap to close, three things must be true. The Seventh Circuit must keep the order stayed or reverse it, and the states' case must end without an unwind of the spin-off or a large payment. PFAS costs must stay within the shared limits of the 2021 agreement, as in the North Carolina settlement of September 2026, where Corteva's share was about $66 million. Crop Protection sales and margins must hold against generic competition.

The first evidence comes with the first report as a stand-alone company on November 11, 2026, and the appeal decision, expected in the next months. If the legal risk falls, the gap can close over 2027, but PFAS claims can take years to end.

1. Nov 11, 2026Pending

   Q3 2026 results: first stand-alone report and outlookStable Crop Protection prices, a stand-alone outlook with growing EBITDA and a clear plan for dividends and buybacks pass; lower prices from generics or a weak stand-alone outlook fail.
2. Q4 2026 · est.Due this quarter

   Seventh Circuit ruling on the restraining orderA stay or reversal of the October 9 order passes; an order that stops dividends and buybacks again fails.
3. 2027 · est.Pending

   States' lawsuit against the spin-offA dismissal or a settlement within the shared PFAS cost limits passes; a ruling that makes Corteva pay large new amounts or unwinds part of the spin-off fails.

Every passed and failed checkpoint across all picks

The latest reported balance sheet, at June 30, 2026, is for the combined company before the spin-off, so its figures do not show the company that remains. At that date, Corteva had $2,365 million of cash and $4,875 million of debt: $3,193 million of short-term borrowings, mostly $2,422 million of commercial paper and $600 million under the 364-day credit facility, and $1,682 million of long-term notes. Read more

• Legacy PFAS liabilities of the old DuPont stay with EIDP, which Corteva owns. Under a 2021 agreement, Corteva, DuPont and Chemours share PFAS costs up to $4 billion of qualified spending, and Chemours' indemnity covers other legacy matters. Large new judgments or settlements can exceed what the market expects.
• Fifteen states and one sovereign sued to challenge the spin-off. A temporary order of October 9, 2026, which stopped dividends, buybacks and asset sales, is stayed during the appeal. If the order comes back, Corteva cannot pay dividends or buy back shares, and a court can try to make Vylor share the liabilities.
• Generic competition lowers prices for crop chemicals. Crop Protection prices fell 4% in Q2 2026, mainly in Latin America. In October 2026, rival FMC cut its Q3 outlook sharply because of cheap generics.
• Corteva is now a smaller company with one business. It has no history of stand-alone results, and it has new costs that the combined company shared before. Its first stand-alone outlook is not known yet.
• Weather, crop prices and farm incomes change how much farmers spend on crop protection each season. Dry weather in Europe lowered volumes in Q2 2026.

• October 15, 2026Rival FMC cut its Q3 2026 outlook sharply because of weak demand and competition from cheap generic products, and its stock fell more than 33%. Citi said that Corteva is less exposed to generic pressure. Corteva stock fell more than 4% that day.
• October 10, 2026The federal court in Indiana stayed its temporary restraining order while Corteva and Vylor ask the Seventh Circuit Court of Appeals to stay it during the appeal. On October 9, the order had stopped Corteva and EIDP from paying dividends, buying back shares and selling assets outside normal business.
• October 6, 2026JPMorgan upgraded Corteva to Overweight from Neutral with a $19 price target, and said that environmental liabilities are the main risk. The stock rose about 11%. Corteva said that it will report Q3 2026 results on November 11, 2026, after the market closes, with a webcast on November 12.